1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Therapeutic Protein Revenue
1.4 Market Analysis by Type
1.4.1 Global Therapeutic Protein Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Erythropoietin
1.4.4 Insulin
1.4.5 Interferon
1.4.6 Human Growth Hormone
1.4.7 Follicle Stimulating Hormone
1.4.8 Blood Clotting Factors
1.5 Market by Application
1.5.1 Global Therapeutic Protein Market Share by Application: 2021-2026
1.5.2 Pharmaceutical Companies
1.5.3 Healthcare Service Providers
1.5.4 Research Organizations
1.5.5 Academic Research Institutes
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Therapeutic Protein Market
1.8.1 Global Therapeutic Protein Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Therapeutic Protein Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Therapeutic Protein Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Therapeutic Protein Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Therapeutic Protein Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Therapeutic Protein Sales Volume Market Share by Region (2015-2020)
3.2 Global Therapeutic Protein Sales Revenue Market Share by Region (2015-2020)
3.3 North America Therapeutic Protein Sales Volume
3.3.1 North America Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.3.2 North America Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Therapeutic Protein Sales Volume
3.4.1 East Asia Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Therapeutic Protein Sales Volume (2015-2020)
3.5.1 Europe Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Therapeutic Protein Sales Volume (2015-2020)
3.6.1 South Asia Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Therapeutic Protein Sales Volume (2015-2020)
3.7.1 Southeast Asia Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Therapeutic Protein Sales Volume (2015-2020)
3.8.1 Middle East Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Therapeutic Protein Sales Volume (2015-2020)
3.9.1 Africa Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Therapeutic Protein Sales Volume (2015-2020)
3.10.1 Oceania Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Therapeutic Protein Sales Volume (2015-2020)
3.11.1 South America Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.11.2 South America Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Therapeutic Protein Sales Volume (2015-2020)
3.12.1 Rest of the World Therapeutic Protein Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Therapeutic Protein Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Therapeutic Protein Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Therapeutic Protein Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Therapeutic Protein Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Therapeutic Protein Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Therapeutic Protein Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Therapeutic Protein Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Therapeutic Protein Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Therapeutic Protein Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Therapeutic Protein Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Therapeutic Protein Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Therapeutic Protein Sales Volume Market Share by Type (2015-2020)
14.2 Global Therapeutic Protein Sales Revenue Market Share by Type (2015-2020)
14.3 Global Therapeutic Protein Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Therapeutic Protein Consumption Volume by Application (2015-2020)
15.2 Global Therapeutic Protein Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Therapeutic Protein Business
16.1 Amgen
16.1.1 Amgen Company Profile
16.1.2 Amgen Therapeutic Protein Product Specification
16.1.3 Amgen Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Eli Lilly
16.2.1 Eli Lilly Company Profile
16.2.2 Eli Lilly Therapeutic Protein Product Specification
16.2.3 Eli Lilly Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Baxter International
16.3.1 Baxter International Company Profile
16.3.2 Baxter International Therapeutic Protein Product Specification
16.3.3 Baxter International Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Abbott Laboratories
16.4.1 Abbott Laboratories Company Profile
16.4.2 Abbott Laboratories Therapeutic Protein Product Specification
16.4.3 Abbott Laboratories Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Diasome Pharmaceuticals
16.5.1 Diasome Pharmaceuticals Company Profile
16.5.2 Diasome Pharmaceuticals Therapeutic Protein Product Specification
16.5.3 Diasome Pharmaceuticals Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 AstraZeneca
16.6.1 AstraZeneca Company Profile
16.6.2 AstraZeneca Therapeutic Protein Product Specification
16.6.3 AstraZeneca Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Generex Biotechnology
16.7.1 Generex Biotechnology Company Profile
16.7.2 Generex Biotechnology Therapeutic Protein Product Specification
16.7.3 Generex Biotechnology Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Chugai Pharmaceutical
16.8.1 Chugai Pharmaceutical Company Profile
16.8.2 Chugai Pharmaceutical Therapeutic Protein Product Specification
16.8.3 Chugai Pharmaceutical Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Boehringer Ingelheim
16.9.1 Boehringer Ingelheim Company Profile
16.9.2 Boehringer Ingelheim Therapeutic Protein Product Specification
16.9.3 Boehringer Ingelheim Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 GeneScience Pharmaceuticals
16.10.1 GeneScience Pharmaceuticals Company Profile
16.10.2 GeneScience Pharmaceuticals Therapeutic Protein Product Specification
16.10.3 GeneScience Pharmaceuticals Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Genentech
16.11.1 Genentech Company Profile
16.11.2 Genentech Therapeutic Protein Product Specification
16.11.3 Genentech Therapeutic Protein Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Therapeutic Protein Manufacturing Cost Analysis
17.1 Therapeutic Protein Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Therapeutic Protein
17.4 Therapeutic Protein Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Therapeutic Protein Distributors List
18.3 Therapeutic Protein Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Therapeutic Protein (2021-2026)
20.2 Global Forecasted Revenue of Therapeutic Protein (2021-2026)
20.3 Global Forecasted Price of Therapeutic Protein (2015-2026)
20.4 Global Forecasted Production of Therapeutic Protein by Region (2021-2026)
20.4.1 North America Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.3 Europe Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.7 Africa Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.9 South America Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Therapeutic Protein Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Therapeutic Protein by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Therapeutic Protein by Country
21.2 East Asia Market Forecasted Consumption of Therapeutic Protein by Country
21.3 Europe Market Forecasted Consumption of Therapeutic Protein by Countriy
21.4 South Asia Forecasted Consumption of Therapeutic Protein by Country
21.5 Southeast Asia Forecasted Consumption of Therapeutic Protein by Country
21.6 Middle East Forecasted Consumption of Therapeutic Protein by Country
21.7 Africa Forecasted Consumption of Therapeutic Protein by Country
21.8 Oceania Forecasted Consumption of Therapeutic Protein by Country
21.9 South America Forecasted Consumption of Therapeutic Protein by Country
21.10 Rest of the world Forecasted Consumption of Therapeutic Protein by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer